Research / UP / Fundamental state Inspectable configuration
State dimensions Filing 0001819516-24-000015 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
49.10% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.61% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation 38th Own-history percentile · N=8
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-53.08% · OPTIONAL · VALID
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
-20.66% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure 0th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
1.63% · OPTIONAL · VALID
Gross margin 25th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.gross_margin
1.66% · CORE · VALID
Operating margin 50th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.operating_margin
-35.39% · CORE · VALID
R&D intensity 88th Own-history percentile · N=8
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
4.94% · OPTIONAL · VALID
SBC intensity 25th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
2.05% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 20 states Self-history eligible
Sep 30, 2021 0/7 normalized Level 3 Mar 31, 2022 0/7 normalized Level 3 Jun 30, 2022 0/7 normalized Level 3 Sep 30, 2022 0/8 normalized Level 3 Sep 30, 2022 0/8 normalized Amended as filed Dec 31, 2022 0/8 normalized Level 3 Mar 31, 2023 0/9 normalized Level 3 Jun 30, 2023 0/9 normalized Level 3 Sep 30, 2023 0/9 normalized Level 3 Dec 31, 2023 6/9 normalized Level 3 Mar 31, 2024 7/9 normalized Level 3 Jun 30, 2024 7/9 normalized Level 3 Sep 30, 2024 8/9 normalized Level 3 Dec 31, 2024 9/9 normalized Level 3 Mar 31, 2025 9/9 normalized Level 3 Jun 30, 2025 9/9 normalized Level 3 Sep 30, 2025 9/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 182.33%
Current 49.10%
Delta -133.24% Capex Intensity Increased
Previous 0.03%
Current 1.61%
Delta 1.57% Cash Generation Increased
Previous -78.05%
Current -53.08%
Delta 24.97% Growth Increased
Previous -23.86%
Current -20.66%
Delta 3.19% Inventory Pressure Decreased
Previous 7.49%
Current 1.63%
Delta -5.86% Margin Decreased
Previous 6.30%
Current 1.66%
Delta -4.64% Profitability Increased
Previous -40.31%
Current -35.39%
Delta 4.92% R And D Intensity Decreased
Previous 6.24%
Current 4.94%
Delta -1.30% Sbc Intensity Increased
Previous 1.10%
Current 2.05%
Delta 0.95% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.